Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02485847 · ClinicalTrials.gov registry record
IRIS Registry: Intelligent Research in Sight Registry
A clinical trial of Eye Diseases, sponsored by American Academy of Ophthalmology.
- Recruiting
- Registry status
- 20,000,000
- Enrollment target
- 1
- Study location
NCT02485847: Recruiting study of Eye Diseases, sponsored by American Academy of Ophthalmology.
NCT02485847 is a study of Eye Diseases that is actively recruiting participants, run by American Academy of Ophthalmology. The registered enrollment target is 20,000,000 participants, above the 562-participant average among 27 other Eye Diseases trials with a reported enrollment target (3558619% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02485847, a study of Eye Diseases, is actively recruiting participants, sponsored by American Academy of Ophthalmology.
- RECRUITING
- Registry status
- 20,000,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.
Primary Outcome
This measure is to be reported a minimum of once per reporting period for patients seen during the reporting period. It is anticipated that clinicians who provide the primary management of patients with primary open-angle glaucoma (in either one or both eyes) will submit this measure.
Conditions Studied
Interventions
- PROCEDURE Ophthalmology
Study Locations (1)
California
- American Academy of Opthalmology - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000,000 participants |
| Start Date | 2014-03 |
| Est. Completion | 2100-01 |
What NCT02485847 shows while recruiting
NCT02485847 is an observational study that tracks outcomes without assigning an intervention. Its 20,000,000 participants enrollment target places it among the larger protocols in the corpus, above the 562-participant average among 27 other Eye Diseases trials with a reported enrollment target (3558619% higher).
The record links to 1 condition, with Eye Diseases appearing as the primary indexed condition, and to 1 intervention - of which Ophthalmology is the first listed.
NCT02485847 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02485847 about?
NCT02485847 is a clinical study titled "IRIS Registry: Intelligent Research in Sight Registry". The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centra...
What is the current status of trial NCT02485847?
This trial is currently recruiting. The enrollment target is 20,000,000 participants. The study started on 2014-03. Estimated completion is 2100-01.
What conditions does trial NCT02485847 study?
This clinical trial studies the following conditions: Eye Diseases.
What interventions are being tested in trial NCT02485847?
The interventions under investigation include: Ophthalmology (PROCEDURE).
Who is sponsoring clinical trial NCT02485847?
This trial is sponsored by American Academy of Ophthalmology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02485847 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02485847's enrollment target sits among peer trials
20,000,000 1st of 27 higher than 27 of 27 other Eye Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eye Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05678699 · 10,000,000 participants · NA
The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
- NCT02693223 · 3,892,063 participants
Get With the Guidelines-Stroke Registry
- NCT06803498 · 3,000,000 participants
Delivery Room Intervention and Evaluation Network
- NCT03813862 · 2,000,000 participants
Observational Pharmaco-Epidemiology Research & Analysis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia